title: [Melatonin participates in the origin and limitation of bone pathohological processes].
abstract: Melatonin, a hormone produced by pineal gland and peripheral tissue cells, controls bone metabolism and is involved in various kinds of the bone pathology through specific receptors. Modern experimental data about its osteogenic activity allow melatonin to be considered as potential drug for treating bone diseases.
authors.forename: É B
authors.initials: ÉB
authors.lastname: Arushanian
mesh_terms: D000375:Aging / Q000378:metabolism*; D000818:Animals; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D050723:Fractures, Bone / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D005786:Gene Expression Regulation; D006801:Humans; D008550:Melatonin / Q000378:metabolism / Q000627:therapeutic use; D010003:Osteoarthritis / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D010024:Osteoporosis / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D010870:Pineal Gland / Q000378:metabolism; D044094:Receptors, Melatonin / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D044094:Receptors, Melatonin; D008550:Melatonin